Sharon H. Giordano, MD, MPH, FASCO
Department of Health Services Research, Division of Cancer Prevention and Population Sciences
About Dr. Giordano
I am the Colin Powell Chair for Cancer Research, Chair of the Department of Health Services Research, and a Professor of Medicine in the Department of Breast Medical Oncology at The University of Texas MD Anderson Cancer Center. My research interests include quality of health care delivery, disparities, and outcomes for cancer patients. I am currently funded through NCI, CPRIT, and Susan G. Komen. I serve as the co-leader of the Risk, Detection and Outcomes Program for the MD Anderson Cancer Center Support Grant. I have over 250 publications and have a track record of continuous funding since 2004. I have served on national guideline committees including as the Chair of ASCO's Clinical Practice Guideline Committee, co-Chair of ASCO's Breast Cancer Guideline Advisory Group and as a member of the NCCN Breast Cancer Guideline Panel. I am the Chair of ASCO's Nominating Committee.
Throughout my career, I have been committed to mentoring and educating junior investigators. I previously coordinated the educational activities for the Department of Breast Medical Oncology and served on the Fellowship Committee. While I managed this rotation, the department was twice selected as Teaching Department of the Year. I received two nominations for the Educator of the Year, and I was nominated the UT Regents Award in Education. In my current position, I consider my most important responsibility to be mentoring and developing the careers of trainees and junior faculty. I have successfully mentored prior trainees on NCI K awards (5), ASCO Young Investigator Grants and DOD grants. My work in mentoring was recognized with the Cancer Medicine Mentor of the Year Award and the MD Anderson President's Faculty Excellence Award in Education and Mentorship.
Experience & Service
Institutional Committee Activities
Member, Advisory Committee, Prostate Center Demonstration Project, 2025 - Present
Member, Charles A. LeMaistre Outstanding Achievement Award in Cancer Selection Committee, 2024 - Present
Member, Academic Policy Council, 2024 - Present
Chair Elect, Committee of Chairs, 2024 - Present
Member, Priority Review Committee for Institutional Philanthropy (PRC), 2024 - Present
Member, Academic Mentoring Council (AMC), 2024 - Present
Member, Standing Committee on Faculty Awards, 2023 - Present
Internal Advisory Committee Member, Texas Health Equity Alliance for Breast Cancer (THEAL), 2023 - Present
Internal Advisory Board Member, Prostate Cancer SPORE, 2023 - Present
Member, Academic Leadership Team Committee, 2023 - Present
Member, Value Task Force, 2022 - 2022
Internal Advisory Board Member, Morgan Welch Inflammatory Breast Cancer Program, 2022 - Present
Member, Faculty Vitality Taskforce, 2019 - 2023
Member, Endowed Positions & Award Committee (EPAC), 2019 - 2022
Voting Rotating Member, Epidemiology Database Access Committee, 2018 - Present
Member, Radiation Oncology Division Head Search Committee, 2018 - 2019
Member, Department of Breast Medical Oncology Assistant Professor (Tenure Track) Search Committee, 2018 - 2022
Chair, Internal Advisory Board, U-HAND (University of Houston/MD Anderson Program to Reduce Cancer Disparities), 2017 - 2022
Advisory Committee Member, Susan G. Komen Training Program to Reduce Breast Cancer Disparities in Black and Hispanic Women, 2017 - 2020
Member, Vice Provost Population Science Advisory Council (VP-PSAC), 2017 - 2018
Member, Community of Science Chairs, 2017 - Present
Member, Community of Chairs, 2017 - Present
Co-Chair, Epidemiology Department Chair Search Committee, 2016 - 2018
Member, Breast Cancer Moonshot Scientific Advisory Board, 2016 - 2017
Co-Chair, Gastroenterology, Hepatology & Nutrition Department Chair Search Committee, 2016 - 2017
Member, UT Population Health Strategic Plan Steering Committee, 2016 - 2016
Distinguished Judge, Cyrus Scholar Awards, The University of Texas MD Anderson Internal Medicine Research Committee, 2015 - 2016
Member, Department of Health Disparities Research Faculty Search Committee, 2015 - 2017
Member, Breast Surgical Oncology Chair Search Committee, 2015 - 2016
Member, Executives and Non-faculty Leaders Team, 2014 - 2015
Member, Clinical Effectiveness Subcommittee, 2014 - 2015
Member, Faculty Diversity, Equity, and Inclusion Committee, 2014 - 2023
Member, Department of Pathology Chair Search Committee, 2014 - 2015
Reviewer, Population Science Abstracts, Trainee Research Day, 2014 - 2014
Member, Department of Breast Medical Oncology Assistant Professor (Tenure Track) Search Committee, 2013 - 2015
Member, MINTOS Grant Review Committee, 2013 - 2013
Executive Advisory Board, Cancer Prevention Research Training Program (CPRTP) Advisory Committee, 2013 - Present
Member, Center for Radiation Oncology Internal Advisory Board, 2013 - 2016
Member, Institutional Research Executive Committee, 2013 - 2016
Member, Gynecologic Oncology and Reproductive Medicine Faculty Search Committee, 2013 - 2013
Executive Committee Member, Duncan Family Institute for Cancer Prevention and Risk Assessment, 2013 - Present
Member, Institute for Cancer Care Innovation Leadership Committee, 2013 - 2017
Member, Institute for Cancer Care Executive Committee, 2013 - 2017
Member, Institutional Review Board IV, 2012 - 2013
Chair, Department of Breast Medical Oncology Assistant Professor (Tenure Track) Search Committee, 2011 - 2012
Member, Division of Cancer Medicine Sixth Annual Faculty Recognition and Awards Program Review Board, 2011 - 2011
Chair, Department of Health Services Research Faculty Search Committee, 2011 - 2011
Member, Department of Breast Medical Oncology Strategic Planning Committee, 2011 - 2012
Member, Health Services Research Chair Search Committee, 2010 - 2010
Chair, Clinical Effectiveness Subcommittee-Breast Cancer, 2008 - 2008
Director, Educational & Training Program, Breast Medical Oncology, 2007 - 2012
Faculty Member, Hematology/Oncology Fellowship Steering Committee, 2007 - 2012
Member, Department of General Internal Medicine Search Committee, 2007 - 2007
Chair, Department of Breast Medical Oncology Concept and Protocol Review Committee, 2007 - 2008
Member, Breast Cancer Guideline Committee, 2007 - 2014
Member, Survivorship Clinical Research Work Group, 2007 - 2007
Member, Clinical Safety and Effectiveness Committee, 2007 - 2007
Member, Pharmacy and Therapeutics Committee, 2006 - 2007
Vice-Chair, Department of Breast Medical Oncology Concept and Protocol Review Committee, 2006 - 2007
Member, Women Faculty Salary Equity Study Group, 2006 - 2007
Committee Vice Chair, Institutional Review Board IV, 2005 - 2012
Member, Breast Center FMEA Committee, 2005 - 2006
Member, Psychosocial, Behavioral, and Health Services Research Committee (PBHSRC), 2005 - 2007
Member, Institutional Review Board III, 2005 - 2012
Associate Member, Institutional Review Board II, 2005 - 2012
Associate Member, Institutional Review Board I, 2005 - 2012
Alternate Member, Pharmacy and Therapeutics Committee, 2004 - 2006
Honors & Awards
| 2024 | Hologic, Inc Endowed Women Who Conquer Cancer Mentorship Award, Conquer Cancer Foundation, American Society of Clinical Oncology |
| 2022 | President's Recognition of Faculty Excellence Award, Clinical Quality Improvement, The University of Texas MD Anderson Cancer Center |
| 2020 | Jack and Beverly Randall Excellence in Cancer Care Award, MD Anderson Cancer Center Jack and Beverly Randall Endowment |
| 2019 | Excellence in LEADership Award, The University of Texas MD Anderson Cancer Center |
| 2019 | President's Recognition of Faculty Excellence Award in Education & Mentorship Advancement, The University of Texas MD Anderson Cancer Center |
| 2017 | Fellow of the American Society of Clinical Oncology, American Society of Clinical Oncology |
| 2015 | Komen Scholar |
| 2013 | The Teaching Department of the Year - Breast Medical Oncology, Division of Cancer Medicine, MD Anderson Cancer Center |
| 2013 | UT Regents' Outstanding Teaching Award Nominee, MD Anderson Cancer Center |
| 2012 | Faculty Scholar Award, The University of Texas MD Anderson Cancer Center |
| 2011 | Division of Cancer Medicine Mentor of the Year, The University of Texas MD Anderson Cancer Center |
| 2010 | Division of Cancer Medicine Distinguished Alumnus Award, The University of Texas MD Anderson Cancer Center |
| 2009 | American Cancer Society Research Scholar, American Cancer Society |
| 2009 | Faculty Educator of the Month - July, The University of Texas MD Anderson Cancer Center |
| 2009 | Gerald P. Bodey Award for Excellence in Education Nominee, The University of Texas MD Anderson Cancer Center |
| 2009 | Tracy Starr Breast Cancer Research Fund Award, Cleveland Foundation |
| 2007 | Fellow, Sealy Center on Aging, The University of Texas Medical Branch at Galveston |
| 2004 | Recipient, NIH Loan Repayment Program, National Institutes of Health |
| 2002 | Breast Medical Oncology Certificates of Appreciation: Highest Revenue per % Effort and Highest Number of RVUs per % Effort, The University of Texas MD Anderson Cancer Center |
| 2002 | M. D. Anderson Trainee Recognition Day Honorable Mention, The University of Texas MD Anderson Cancer Center |
| 2001 | ASCO Merit Award Recipient, American Society of Clinical Oncology |
| 2001 | Outstanding New Student Award, UT School of Public Health |
| 1996 | Alpha Omega Alpha, Johns Hopkins University School of Medicine |
| 1991 | Graduated With Distinction in Biology and Summa Cum Laude, Yale University |
| 1990 | Outstanding Student in Organic Chemistry Laboratory, Yale University |
Professional Memberships
Selected Presentations & Talks
Local Presentations
- 2022. Systemic Therapy for Early Breast Cancer. Invited. 2022 Comprehensive Board Review in Hematology and Medical Oncology. Houston, Texas, US.
- 2022. Introduction to Health Services Research. Invited. Monthly Abdominal Imaging Research Lecture Series (MARS). Houston, Texas, US.
- 2014. Breakthrough Houston College Prep Enrichment Program. Invited. MD Anderson Women Faculty Programs. Houston, Texas, US.
- 2014. Opportunities in Health Services Research. Invited. Clinical Research and Education Unit (CREU). Houston, Texas, US.
- 2014. Work Life Integration Seminar. Invited. Hematology and Medical Oncology Fellowship Program. Houston, Texas, US.
- 2014. Opportunities in Health Services Research. Invited. Cancer Prevention and Control Grand Rounds. Houston, Texas, US.
- 2013. Male Breast Cancer. Invited. The SCAR Project. Houston, Texas, US.
- 2013. Panel Discussion: Health Services Research: A New Horizon. Invited. Women Executives in Science & Healthcare. Houston, Texas, US.
- 2012. Breast Cancer: Progress Through Understanding. Invited. Inaugural Hope in Houston: Hot Pink Luncheon. Houston, Texas, US.
- 2012. Outcomes and Quality of Cancer Treatment in Cancer Survivors. Invited. Advances in Oncology Institutional Grand Rounds. Houston, Texas, US.
- 2011. Metastatic Breast Cancer. Invited. Hematology and Medical Oncology Fellowship Program. Houston, Texas, US.
- 2011. Metastatic Breast Cancer: HER2 Negative. Invited. Hematology and Medical Oncology Fellowship Program. Houston, Texas, US.
- 2011. Cardiac Toxicity in Breast Cancer Survivors. Invited. Grands Rounds. Houston, Texas, US.
- 2010. Potential Research Applications of Cancer Registry and Administrative Datasets. Invited. Health Services Research Journal Club. Houston, Texas, US.
- 2010. HSR Today at MD Anderson Cancer Center. Invited. Health Services Research Retreat. Houston, Texas, US.
- 2010. Potential Research Applications of Cancer Registry and Administrative Datasets. Invited. Division of Cancer Medicine Grand Rounds. Houston, Texas, US.
- 2009. Male Breast Cancer. Invited. Core Curriculum Lecture. Houston, Texas, US.
- 2009. Male Breast Cancer. Invited. Breast Cancer Nurses Lecture Series. Houston, Texas, US.
- 2009. Male Breast Cancer. Invited. Core Curriculum Lecture. Houston, Texas, US.
- 2009. Treatment Paradigm for Breast Cancer. Invited. The Gynecology Oncology Fellowship Program Education Conference. Houston, Texas, US.
- 2007. Breast Cancer in Men, The Surgical Breast Education Conference. Invited. The Surgical Oncology Fellowship and Breast Surgical Oncology Fellowship Program. Houston, Texas, US.
- 2007. Principles of Male Breast Cancer. Invited. Core Curriculum Lecture. Houston, Texas, US.
- 2006. Uses of SEER and SEER-Medicare Data in Cancer Research. Invited. Cancer Medicine Grand Rounds. Houston, Texas, US.
- 2006. Uses of SEER and SEER-Medicare Data in Cancer Research. Invited. Department of Internal Medicine Research Conference. Houston, Texas, US.
- 2005. Cardiac Morbidity of Adjuvant Radiotherapy (ART) in Patients with Early Stage Breast Cancer Poster Presentation. Invited. Houston, Texas, US.
- 2005. Diagnosis and Treatment of Primary Breast Cancer. Invited. 27th annual Pharmacy Symposium on Cancer Chemotherapy. Houston, Texas, US.
- 2004. Male Breast Cancer. Invited. Houston, Texas, US.
- 2004. Effects of Treatment and Survivorship of Advanced Breast Cancer. Invited. Grand Rounds and Alice Judkins Lectureship. Houston, Texas, US.
- 2003. Breast Cancer in Men. Invited. Grand Rounds. Houston, Texas, US.
Regional Presentations
- 2018. Toxicities of Breast Cancer Treatments. Invited. 2018 Scholar Breakfast. Plano, TX, US.
- 2015. Panel Discussion: Cancer Survivorship: Improving Care and Quality of Life. Invited. Fort Worth, TX, US.
- 2015. Toxicities of Breast Cancer Treatment. Invited. Fort Worth, TX, US.
- 2010. Use of SEER-Medicare Data in Cancer Treatment and Outcomes Research. Invited. Cancer Center Grand Rounds. Galveston, TX, US.
National Presentations
- 2024. Systemic Therapy for Breast Cancer. Invited. 2024 Comprehensive Board Review in Hematology and Medical Oncology, US.
- 2024. Assessing early and late toxicities of cancer treatment with registry-based data. Invited. UNC, NC, US.
- 2024. Assessing early and late toxicities of cancer treatment with registry-based data. Invited. Cancer Outcomes Research, NC, US.
- 2023. Male Breast Cancer. Invited, US.
- 2023. Male Patients With Breast Cancer: Special Considerations and Gender-Specific Concerns. Invited, US.
- 2023. Determinants of Health in the Marginalized: Mechanisms and Mediators. Conference. Chicago, IL, US.
- 2022. Systemic Therapy for Early Breast Cancer. Invited. 2022 Comprehensive Board Review in Hematology and Medical Oncology, US.
- 2021. Special Issues in Breast Cancer. Invited. 2021 Comprehensive Board Review in Hematology and Medical Oncology. Houston, TX, US.
- 2019. The Toll on Health Care Providers. Conference. San Antonio, TX, US.
- 2019. Male Breast Cancer. Invited. Current Controversies Meeting. Boston, MA, US.
- 2018. Session Chair. Conference. Spotlight Session: Quality of Life, Survivorship and Cost of Care. San Antonio, TX, US.
- 2018. Special Issues in Breast Cancer. Invited. 2018 Comprehensive Board Review in Hematology and Medical Oncology. Houston, TX, US.
- 2018. Highlights in Male Breast Cancer. Invited. 2018 Best of ASCO Puerto Rico. Puerto Rico, PR, US.
- 2018. Updates on HER2-Positive Breast Cancer Treatment. Invited. Orlando, FL, US.
- 2018. Toxicities of Breast Cancer Treatments. Invited. Susan G. Komen North Texas Breast Health Lecture Series. Plano, TX, US.
- 2017. Poster Discussant. Conference. Spotlight Session - Cost/Fertility Preservation/Male Breast Cancer. San Antonio, TX, US.
- 2016. Special Issues in Breast Cancer. Invited. 2016 Comprehensive Board Review in Hematology and Medical Oncology. Houston, TX, US.
- 2016. Discussant. Conference. Oral Abstract Session B Breakout 2: Science of Quality. Chicago, IL, US.
- 2015. Special Issues in Breast Cancer. Invited. 2015 Comprehensive Board Review in Hematology and Medical Oncology. Houston, TX, US.
- 2015. Overview of Comparative Effectiveness Research and Observational Study Design. Conference. Chicago, IL, US.
- 2015. Use of Registry and Administrative Data in Cancer Outcomes Research. Invited. San Juan, PR, US.
- 2015. Use of Registry and Administrative Data in Cancer Outcomes Research. Invited. University of Puerto Rico Medical Sciences Grand Rounds. San Juan, PR, US.
- 2015. Assessing Toxicity of Therapy with Administrative Data. Invited. Boston, MA, US.
- 2015. Assessing Toxicity of Therapy with Administrative Data. Invited. Dana-Farber Cancer Institute Breast Oncology Seminar. Boston, MA, US.
- 2014. Special Issues in Breast Cancer. Invited. 2014 Comprehensive Board Review in Hematology and Medical Oncology. Houston, TX, US.
- 2014. Long-Term Health Outcomes. Conference. 2014 Breast Cancer Symposium. San Francisco, CA, US.
- 2014. Scientific Discussant. Conference. Breast Cancer - HER2/ER Oral Abstract Session. Chicago, IL, US.
- 2013. Special Issues in Breast Cancer. Invited. 2013 Comprehensive Board Review in Hematology and Medical Oncology. Houston, TX, US.
- 2012. Special Issues in Breast Cancer. Invited. 2012 Comprehensive Board Review in Hematology and Medical Oncology. Houston, TX, US.
- 2012. Scientific Discussant. Conference. Health Services Research Poster Session. Chicago, IL, US.
- 2011. Special Issues in Breast Cancer. Invited. 2011 Comprehensive Board Review in Hematology and Medical Oncology. Houston, TX, US.
- 2010. Special Issues in Breast Cancer. Invited. 2010 Comprehensive Board Review in Hematology and Medical Oncology. Houston, TX, US.
- 2010. Impact of Comorbid Conditions on Breast Cancer Survivorship. Conference. Chicago, IL, US.
- 2010. Use of SEER-Medicare Data in Cancer Treatment and Outcomes Research. Invited. The University of Texas Medical Branch Cancer Center. Galveston, TX, US.
- 2009. Special Issues in Breast Cancer. Invited. 2009 Comprehensive Board Review in Hematology and Medical Oncology. Houston, TX, US.
- 2009. Current Update on Medical Oncology Approach to Common Malignancies: Breast Cancer - What the Surgeon Needs to Know. Invited. AO North America and AO Spine North America. Houston, TX, US.
- 2008. New Options for Metastatic Breast Cancer. Invited. Amarillo, TX, US.
- 2008. Expert Discussion of Breast Cancer Nursing Practice Patterns: Adjuvant Therapies. Invited. Seattle, WA, US.
- 2008. Risk and Prognostic Factors. Invited. Male Breast Cancer Meeting: A Multidisciplinary Scientific Update Meeting. Rockville, MD, US.
- 2008. Anthracyclines and HER2 Inhibitors: Benefits vs. Risks. Invited. Philadelphia, PA, US.
- 2008. Advanced Disease Therapy. Invited. Breast Cancer Highlights Meeting. Santa Monica, CA, US.
- 2008. Sequence of Treatment in Stage 4 Disease. Invited. 8th Annual Oncology Update: Advances and Controversies. Park City, UT, US.
- 2007. Update on the Treatment of Early Stage Breast Cancer. Invited. Santa Barbara, CA, US.
- 2007. Update on the Treatment of Metastatic Breast Cancer. Invited. Santa Barbara, CA, US.
- 2007. Treatment Patterns for Breast Cancer. Invited. CISNET Breast Mid-Year Meeting. Houston, TX, US.
- 2007. Treatment Options for Anthracycline and Taxane Refractory Metastatic Breast Cancer. Invited. Reality Hematology/Oncology Meeting. St. Louis, MO, US.
- 2007. Management of HER-2 Positive Metastatic Breast Cancer. Invited. Reality Hematology/Oncology Meeting. St. Louis, MO, US.
- 2007. Update from San Antonio Breast Cancer Symposium. Invited. Chicago, IL, US.
- 2007. Update from San Antonio Breast Cancer Symposium. Invited. San Francisco, CA, US.
- 2006. Inflammatory Breast Cancer. Invited. Boston, MA, US.
- 2006. Update on the Treatment of Early Stage Breast Cancer. Invited. Baton Rouge, LA, US.
- 2006. Update on the Management of Early Stage Breast Cancer. Invited. M. D. Anderson Physicians Network Second Annual Symposium. Kauai, HI, US.
- 2006. Role of Molecular Prognostic and Predictive Factors in Clinical Practice. Invited. M. D. Anderson Physicians Network Second Annual Symposium. Kauai, HI, US.
- 2006. Advances in the Management of HER-2 Overexpressing Breast Cancer. Invited. M. D. Anderson Physicians Network Second Annual Symposium. Kauai, HI, US.
- 2006. Update from San Antonio Breast Cancer Symposium. Invited. San Francisco, CA, US.
- 2005. Cardiac Toxicity. Invited. Boston, MA, US.
- 2005. Update from ASCO Annual Meeting. Invited. Rochester, NY, US.
- 2004. Breast Cancer in 2004: An Overview. Invited. Grand Rounds. Racine, WI, US.
- 2004. Special Issues in Breast Cancer. Invited. 2004 Comprehensive Board Review in Hematology and Medical Oncology. Houston, TX, US.
- 2004. Breast Cancer in 2004: An Overview. Invited. St. Mary's Medical Center. Racine, WI, US.
- 2004. Breast Cancer in Men. Invited. 9th Annual Oncology Conference. Lake Ozark, MO, US.
- 2003. Special Issues in Breast Cancer. Invited. 2003 Comprehensive Board Review in Hematology and Medical Oncology. Houston, TX, US.
International Presentations
- 2023. Systemic Therapy for Male Breast Cancer. Invited. Brussels.
- 2021. Panel Discussant. Invited. Optimal Locoregional Therapy: Treating the Axilla In Women with Breast Cancer. Virtual Worldwide.
- 2021. Adjuvant Decision Making In the Era of Limited Nodal Information. Conference. Virtual Worldwide.
- 2019. Extrapolating Data From Clinical Trials As We Are Treating Patients in Real Life. Conference. Vienna.
- 2018. Update on the Use of Potentially Cardiotoxic Therapy for the Treatment of Breast Cancer. Invited. Naples.
- 2018. Using Cancer Registry and Administrative Data to Assess Risk of Cardiotoxicity in Patients with Breast Cancer. Invited. Naples.
- 2015. Toxicities of Breast Cancer Therapies. Invited. Breast Cancer Symposium. Paris.
- 2010. Male Breast Cancer. Invited. e-grandrounds. Houston, US.
- 2009. Update on National Comprehensive Cancer Network: Breast Cancer Registry and Guidelines. Invited. Osaka.
- 2008. Cardiac Toxicity of Anthracyclines. Invited. Paris.
- 2007. Adjuvant Therapy for Post-Menopausal Women with Breast Cancer. Invited. Second National Congress of Mastology. Cartagena.
- 2007. Long Term Toxicities of Breast Cancer Therapy. Invited. Second National Congress of Mastology. Cartagena.
- 2007. Survival Benefit of Screening Mammography. Invited. Second National Congress of Mastology. Cartagena.
- 2007. Update on Trastuzumab in the Treatment of Breast Cancer. Invited. Veracruz.
- 2007. Update on Trastuzumab in the Treatment of Breast Cancer. Invited. Tijuana.
- 2006. Cardiac Toxicity of Adjuvant Anthracyclines Among Older Women with Breast Cancer. Invited. London, GB.
Grant & Contract Support
| Date: | 2025 - 2030 |
| Title: | UPR/MDACC Partnership for Excellence in Cancer Research |
| Funding Source: | NCI |
| Role: | PI |
| Date: | 2025 - Present |
| Title: | UTMB Women's health research scholars program |
| Funding Source: | Institutional Research Career Development Award (BIRCWH) |
| Role: | Mentor |
| Date: | 2024 - 2025 |
| Title: | Delays in Timely Initiation of Treatment for Men with Prostate Cancer In Botswana |
| Funding Source: | Young Investigator Award, ASCO |
| Role: | Mentor |
| Date: | 2024 - 2025 |
| Title: | Disparities in Guideline Concordant BRCA Testing for Medicare Advantage versus Traditional Medicare Beneficiaries with Breast, Ovarian, Pancreatic, and Prostate Cancers |
| Funding Source: | Young Investigator Award, ASCO |
| Role: | Mentor |
| Date: | 2024 - 2026 |
| Title: | Robert A. Winn Diversity In Clinical Trials: Career Development Award |
| Funding Source: | Robert Winn Diversity in Clinical Trials Program |
| Role: | Mentor |
| Date: | 2023 - 2024 |
| Title: | Cancer Care Delivery and Breast Cancer: Impact and Associated Factors |
| Funding Source: | Breast Cancer Research Foundation |
| Role: | Co-I |
| ID: | FP00022690 |
| Date: | 2023 - 2028 |
| Title: | Methods Training for Comparative Effectiveness Research in Cancer |
| Funding Source: | NIH/NCI |
| Role: | Co-I |
| ID: | R25CA257883 |
| Date: | 2022 - 2023 |
| Title: | Treatment Non-Completion Among Patients with Breast Cancer: Impact and Associated Factors |
| Funding Source: | Breast Cancer Research Foundation (BCRF) |
| Role: | Collaborator |
| ID: | BCRF-22-190 |
| Date: | 2022 - 2023 |
| Title: | Disparities in Adherence to Oral Anticancer Medications and Specialty Pharmacy Use |
| Funding Source: | Young Investigator Award, ASCO |
| Role: | Mentor |
| Date: | 2022 - 2027 |
| Title: | Skin Cancer Risks and Risk Prediction in Patients with Actinic Keratosis |
| Funding Source: | NIH/NCI |
| Role: | Mentor |
| ID: | 1K08CA263298-01A1 |
| Date: | 2022 - 2025 |
| Title: | Breast Cancer Treatment Initiation and Completion |
| Funding Source: | Komen Scholars |
| Role: | Collaborator |
| ID: | SAC220221 |
| Date: | 2021 - 2026 |
| Title: | Training Academic Gynecologic Oncologists |
| Funding Source: | NIH/NCI |
| Role: | Mentor |
| Date: | 2021 - 2026 |
| Title: | Data Management and Analysis Core for Comparative Effectiveness Research on Cancer in Texas |
| Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
| Role: | Co-I |
| ID: | RP210130 |
| Date: | 2021 - 2026 |
| Title: | Writing to Heal: A Culturally Based Brief Expressive Intervention for Chinese Immigrant Breast Cancer Survivors |
| Funding Source: | NIH/NCI |
| Role: | Co-I |
| ID: | R01CA248213 |
| Date: | 2021 - 2026 |
| Title: | Health Benefits of Writing Therapy Among Chinese Breast Cancer Survivors |
| Funding Source: | American Cancer Society (ACS) |
| Role: | Co-I |
| ID: | RSG-21-040-01-CPPB |
| Date: | 2021 - 2026 |
| Title: | Impact of Clonal Hematopoiesis Mutations on Toxicity and Outcomes Following Oncologic Therapy |
| Funding Source: | NIH/NCI |
| Role: | Mentor |
| ID: | K08CA263313 |
| Date: | 2021 - 2025 |
| Title: | Effects of Biologic and Targeted Therapies for Rheumatoid Arthritis on Cancer Outcomes |
| Funding Source: | NIH/NCI |
| Role: | Co-PI |
| ID: | R01AR078484 |
| Date: | 2019 - 2025 |
| Title: | UPR/MDACC: Partnership for Excellence in Cancer Research |
| Funding Source: | NIH/NCI |
| Role: | Contact-Principal Investigator |
| ID: | U54CA096300 |
| Date: | 2019 - 2024 |
| Title: | Developing a Decision Aid for Chemotherapy in Older Women with Early Stage Breast Cancer |
| Funding Source: | NIH/NCI |
| Role: | Mentor |
| ID: | K08CA241087 |
| Date: | 2018 - 2025 |
| Title: | Assess: A Novel Breast Cancer Decision Support Tool |
| Funding Source: | Susan G. Komen Breast Cancer Foundation |
| Role: | PI |
| ID: | OG180002 |
| Date: | 2018 - 2023 |
| Title: | Obstetrical and Oncological Outcomes Among Reproductive Age Women with Gynecological and Breast Cancer |
| Funding Source: | NIH/NCI |
| Role: | Mentor |
| ID: | K08 CA2334333 |
| Date: | 2018 - 2023 |
| Title: | Genetic Testing in Young Women for Cancer Prevention |
| Funding Source: | NIH/NCI |
| Role: | Mentoring advisory committee |
| ID: | K07 CA222343 |
| Date: | 2016 - 2017 |
| Title: | International Male Breast Cancer Program of EORTC/TBCRC/BIG/NABCG: Understanding the Biology for Improved Patient Care. In Search of Valuable Biomarkers |
| Funding Source: | Breast Cancer Research Foundation |
| Role: | Co-PI |
| Date: | 2016 - 2021 |
| Title: | Economic Strain and Resilience in Cancer Patients: Assessing Patient-Reported Measures of the Burdens of Treatment |
| Funding Source: | NIH/NCI |
| Role: | Mentor |
| ID: | 5 K07 CA211804 |
| Date: | 2016 - 2017 |
| Title: | CCSG Supplement: Health Assessment to Advance Cancer Prevention, Screening, and Control in the MD Anderson Catchment Area: The State of Texas |
| Funding Source: | NIH/NCI |
| Role: | Co-I |
| ID: | 3 P30 CA016672-41S6 |
| Date: | 2016 - 2023 |
| Title: | Technology Diffusion in Cancer: Geographic Variations, Facilitators, Outcomes, and Costs |
| Funding Source: | NIH/NCI |
| Role: | Co-I |
| ID: | R01 CA207216-01 |
| Date: | 2016 - 2022 |
| Title: | Comparative Effectiveness Research on Cancer in Texas (CERCIT) 2.0: Admin Core |
| Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
| Role: | Co-PI |
| ID: | RP160674-Admin Core |
| Date: | 2016 - 2022 |
| Title: | Chemotherapy Treatment Choices in Older Patients with Cancer |
| Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
| Role: | PI |
| ID: | RP160674-P2 |
| Date: | 2016 - 2026 |
| Title: | Cancer Center Support Grant: Cancer Risks and Outcomes Program |
| Funding Source: | NIH/NCI |
| Role: | Co-Leader |
| ID: | P30CA016672 |
| Date: | 2016 - 2018 |
| Title: | Developing a Decision Aid for Adjuvant Chemotherapy in Elderly Women with Early Stage Breast Cancer |
| Funding Source: | The University of Texas MD Anderson Cancer Center |
| Role: | Co-I |
| Date: | 2016 - 2022 |
| Title: | Health Services Career Development: Improving Medical Decisions in Ovarian Cancer |
| Funding Source: | NIH/NCI |
| Role: | Mentor |
| ID: | K07 CA201013 |
| Date: | 2016 - 2018 |
| Title: | Economic Strain in Cancer Patients (Pilot Study) |
| Funding Source: | The University of Texas MD Anderson Cancer Center |
| Role: | Co-I |
| Date: | 2015 - 2025 |
| Title: | Toxicities of Breast Cancer Treatment |
| Funding Source: | Susan G. Komen Breast Cancer Foundation |
| Role: | PI |
| ID: | SAC150061 |
| Date: | 2015 - 2018 |
| Title: | Human Papillomavirus (HPV)-Associated Second Malignancies in Patients Who Receive Allogeneic Stem Cell Transplantation |
| Funding Source: | Duncan Family Institute |
| Role: | Collaborator |
| Date: | 2015 - 2016 |
| Title: | Trends, Utilization and Risk of Hospitalization, Toxicity and Outcomes Following Radiotherapy Compared to Other Primary Treatments for Prostate Cancer |
| Funding Source: | The Center for Radiation Oncology Research, The University of Texas MD Anderson Cancer Center |
| Role: | Mentor |
| Date: | 2014 - 2016 |
| Title: | International Male Breast Cancer Program EORTC/TBCRC/BIG/NABCG: Deeper Characterization by RNA Sequencing |
| Funding Source: | Breast Cancer Research Foundation |
| Role: | Co-PI |
| Date: | 2014 - 2019 |
| Title: | Methods for Training in Patient-Centered Cancer Outcomes Research |
| Funding Source: | Agency for Healthcare Research and Quality |
| Role: | Co-I |
| ID: | 1 R25 HS023214 |
| Date: | 2014 - 2015 |
| Title: | The Impact of Potentially Inappropriate Medication Prescribing in Elderly Cancer Patients Receiving Chemotherapy |
| Funding Source: | American Society of Clinical Oncology (ASCO) |
| Role: | Mentor |
| Date: | 2014 - 2018 |
| Title: | A Clinical and Biological Characterization of Male Breast Cancer: An International EORTC, BIG, and NABCG Intergroup Study |
| Funding Source: | Susan G. Komen Breast Cancer Foundation |
| Role: | PI |
| ID: | OGEORT1301 |
| Date: | 2014 - 2016 |
| Title: | Comparative Effectiveness Research on Cancer in Texas (CERCIT) |
| Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
| Role: | Co-Administrative Leader |
| ID: | RP140020-AC |
| Date: | 2013 - 2016 |
| Title: | Creating a Core Data Resource for Health Services Research |
| Funding Source: | Duncan Family Institute |
| Role: | PI |
| Date: | 2013 - 2017 |
| Title: | Patient Care Outcome Research in the Elderly |
| Funding Source: | Agency for Healthcare Research and Quality |
| Role: | Co-I |
| ID: | 1 R24 HS022134-01 |
| Date: | 2012 - 2018 |
| Title: | Multimodal MRI Biomarker of Mild Cognitive Impairment in Breast Cancer |
| Funding Source: | NIH/NCI |
| Role: | Collaborator |
| ID: | 1R01NR014195 |
| Date: | 2012 - 2014 |
| Title: | Using Claims Data to Evaluate Radiation Therapy Utilization at the End of Life |
| Funding Source: | NIH/NCI |
| Role: | Co-I |
| ID: | 5 R21 CA164449-02 |
| Date: | 2011 - 2016 |
| Title: | Innovative Methods for Modeling Longitudinal Medical Costs |
| Funding Source: | Agency for Healthcare Research and Quality |
| Role: | Consult |
| ID: | R01 HS020263 |
| Date: | 2011 - 2013 |
| Title: | Technology Diffusion & Cost-Effectiveness of Mammography Screening in Older Women |
| Funding Source: | NIH/NCI |
| Role: | Co-I |
| ID: | 1 R21 CA165092-01 |
| Date: | 2010 - 2014 |
| Title: | Male Breast Cancer: Understanding the Biology for an Improved Patient Care |
| Funding Source: | Breast Cancer Research Foundation |
| Role: | Co-PI |
| Date: | 2010 - 2016 |
| Title: | CERCIT: Comparative Effectiveness Research on Cancer in Texas |
| Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
| Role: | Co-I |
| ID: | RP101207 |
| Date: | 2010 - 2016 |
| Title: | Assessing the Quality of Cancer Treatment in Texas |
| Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
| Role: | PI |
| ID: | RP140020-P2 |
| Date: | 2010 - 2016 |
| Title: | Quality of Supportive Care of Texans with Cancer (Project 4) - Comparative Effectiveness Research on Cancer in Texas |
| Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
| Role: | Co-I |
| ID: | RP140020-P4 |
| Date: | 2009 - 2010 |
| Title: | Adherence Among Older Women with Breast Cancer |
| Funding Source: | NIH/NCI |
| Role: | PI |
| ID: | 3K07-CA109064-05 S1 |
| Date: | 2009 - 2013 |
| Title: | Monoclonal Antibodies in Cancer Care: Is Underinsurance an Access Barrier? |
| Funding Source: | DHHS/AHRQ |
| Role: | Co-I |
| ID: | 1-R02-HS018535-01 |
| Date: | 2009 - 2014 |
| Title: | Off-Label Chemotherapy for Treatment of Cancer: Patterns, Predictors, Risks |
| Funding Source: | American Cancer Society (ACS) |
| Role: | PI |
| ID: | RSGI-09-149-01-CPHPS |
| Date: | 2009 - 2012 |
| Title: | Optimizing the Delivery of Lifestyle Interventions |
| Funding Source: | The University of Texas M. D. Anderson Cancer Center |
| Role: | Co-I |
| Date: | 2009 - 2012 |
| Title: | Tracy Starr Breast Cancer Research Fund Award |
| Funding Source: | Cleveland Foundation |
| Role: | PI |
| ID: | L2009-0053 |
| Date: | 2009 - 2011 |
| Title: | Take Heart: Exercise & Diet Intervention for Heart Failure in Cancer Survivors |
| Funding Source: | NIH/NCI |
| Role: | Other Significant Contributor |
| ID: | CA135016-01A1 |
| Date: | 2008 - 2010 |
| Title: | Association of Breast Cancer and Its Therapies with Fracture |
| Funding Source: | NIH/NCI |
| Role: | Co-I |
| ID: | R21-CA131643-01A1 |
| Date: | 2008 - 2023 |
| Title: | Training of Academic Surgical Oncologists |
| Funding Source: | NIH/NCI |
| Role: | Mentor |
| ID: | S T32 CA009599 |
| Date: | 2007 - 2010 |
| Title: | Disparities in Mammography Screening in the Rural South |
| Funding Source: | Susan G. Komen Breast Cancer Foundation |
| Role: | Co-I |
| ID: | DISP0707435 03 |
| Date: | 2007 - 2011 |
| Title: | Patterns of Care and Disparities in the Treatment of Early Breast Cancer |
| Funding Source: | Department of Defense |
| Role: | Mentor |
| ID: | W81XWH-07-1-0669 03 |
| Date: | 2007 - 2007 |
| Title: | Surviving Cancer: Healthcare and Information Needs |
| Funding Source: | Texas Medical Center Fleming and Davenport Award |
| Role: | Co-I |
| Date: | 2006 - 2010 |
| Title: | Late Consequences of Therapy in Breast Cancer Survivors |
| Funding Source: | Texas Federation of Business and Professional Women's Clubs |
| Role: | PI |
| Date: | 2006 - 2007 |
| Title: | Risk of AML after Adjuvant Therapy For Breast Cancer |
| Funding Source: | Young Investigator Award, ASCO |
| Role: | Mentor |
| Date: | 2005 - 2007 |
| Title: | Burden of Breast Cancer Related Lymphedema on Working American Families |
| Funding Source: | American Cancer Society (ACS) |
| Role: | Co-I |
| ID: | RSGTL-05-093-01-CPHP |
| Date: | 2004 - 2010 |
| Title: | Adherence Among Older Women with Breast Cancer |
| Funding Source: | NIH/NCI |
| Role: | PI |
| ID: | 1K07CA109064-05 |
Patient Reviews
CV information above last modified March 20, 2025